Total submissions: 12
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000081603 | SCV000113534 | benign | not specified | 2015-08-20 | criteria provided, single submitter | clinical testing | |
Genetic Services Laboratory, |
RCV000081603 | SCV000150765 | benign | not specified | 2014-01-24 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000081603 | SCV000167816 | benign | not specified | 2013-05-30 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Prevention |
RCV000081603 | SCV000312077 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Athena Diagnostics | RCV000576591 | SCV000677262 | benign | Cortical dysplasia-focal epilepsy syndrome | 2017-04-28 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000576591 | SCV000766460 | benign | Cortical dysplasia-focal epilepsy syndrome | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000576591 | SCV001326178 | likely benign | Cortical dysplasia-focal epilepsy syndrome | 2018-01-12 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. |
Pathology and Clinical Laboratory Medicine, |
RCV000081603 | SCV001438964 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Center for Genomics, |
RCV003224139 | SCV003919814 | uncertain significance | Autism, susceptibility to, 15; Cortical dysplasia-focal epilepsy syndrome | 2021-03-30 | criteria provided, single submitter | clinical testing | CNTNAP2 NM_014141 exon 23 c.3716-6C>G: This variant has not been reported in the literature but is present in 12% (1198/9918) of African individuals, including 400 homozygotes in the Genome Aggregation Database (http://gnomad.broadinstitute.org/rs374969707). This variant is present in ClinVar, with several labs classifying this variant as benign (Variation ID: 95572). Evolutionary conservation and computational predictive tools for this variant are limited or unavailable. In summary, data on this variant suggests that this variant does not cause disease, but requires further evidence. Therefore this variant is classified as Likely Benign. |
Breakthrough Genomics, |
RCV004706503 | SCV005219811 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Genome Diagnostics Laboratory, |
RCV000081603 | SCV001926341 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000081603 | SCV001971206 | benign | not specified | no assertion criteria provided | clinical testing |